1. Home
  2. LWLG vs ARDX Comparison

LWLG vs ARDX Comparison

Compare LWLG & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

N/A

Current Price

$3.01

Market Cap

625.9M

Sector

Industrials

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.07

Market Cap

724.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LWLG
ARDX
Founded
1991
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
625.9M
724.0M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
LWLG
ARDX
Price
$3.01
$3.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$7.00
★ $12.50
AVG Volume (30 Days)
3.6M
★ 4.3M
Earning Date
11-10-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 15.79
N/A
EPS
★ N/A
N/A
Revenue
$236,855.00
★ $2,607,000.00
Revenue This Year
N/A
$18.39
Revenue Next Year
$257.14
$26.08
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 147.74
N/A
52 Week Low
$2.83
$2.80
52 Week High
$18.71
$8.40

Technical Indicators

Market Signals
Indicator
LWLG
ARDX
Relative Strength Index (RSI) 33.95 45.21
Support Level N/A $2.88
Resistance Level $5.73 $3.38
Average True Range (ATR) 0.45 0.17
MACD -0.12 0.02
Stochastic Oscillator 8.79 38.52

Price Performance

Historical Comparison
LWLG
ARDX

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: